VRPX · Categories · Form 4
VRPX - SEC Form 4 insider transactions
Virpax Pharmaceuticals Inc. (VRPX) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for VRPX
- SEC Form 4 filed by Director Field Katharyn4 - Virpax Pharmaceuticals, Inc. (0001708331) (Issuer)
- SEC Form 4 filed by Director Herman Gary L4 - Virpax Pharmaceuticals, Inc. (0001708331) (Issuer)
- SEC Form 4 filed by Director Dhaliwal Jatinder4 - Virpax Pharmaceuticals, Inc. (0001708331) (Issuer)
- SEC Form 4 filed by Shah Vinay4 - Virpax Pharmaceuticals, Inc. (0001708331) (Issuer)
- SEC Form 4 filed by Singh Vanila4 - Virpax Pharmaceuticals, Inc. (0001708331) (Issuer)
- SEC Form 4 filed by Jambulingam Thani4 - Virpax Pharmaceuticals, Inc. (0001708331) (Issuer)
- SEC Form 4 filed by Dubin Michael F4 - Virpax Pharmaceuticals, Inc. (0001708331) (Issuer)
- SEC Form 4 filed by Mathias Sheila4 - Virpax Pharmaceuticals, Inc. (0001708331) (Issuer)
- SEC Form 4 filed by Sendrow Jerrold4 - Virpax Pharmaceuticals, Inc. (0001708331) (Issuer)
- SEC Form 4 filed by Bruce Gerald W4 - Virpax Pharmaceuticals, Inc. (0001708331) (Issuer)
- SEC Form 4 filed by Floyd Eric4 - Virpax Pharmaceuticals, Inc. (0001708331) (Issuer)
- SEC Form 4 filed by Ruskin Barbara4 - Virpax Pharmaceuticals, Inc. (0001708331) (Issuer)
- SEC Form 4 filed by Shah Vinay (Amendment)4/A - Virpax Pharmaceuticals, Inc. (0001708331) (Issuer)
- SEC Form 4 filed by Shah Vinay4 - Virpax Pharmaceuticals, Inc. (0001708331) (Issuer)
- SEC Form 4 filed by Bruce Gerald W4 - Virpax Pharmaceuticals, Inc. (0001708331) (Issuer)
- SEC Form 4 filed by Ruskin Barbara4 - Virpax Pharmaceuticals, Inc. (0001708331) (Issuer)
- SEC Form 4 filed by Mack Anthony P. (Amendment)4/A - Virpax Pharmaceuticals, Inc. (0001708331) (Issuer)
- SEC Form 4 filed by Mack Anthony P.4 - Virpax Pharmaceuticals, Inc. (0001708331) (Issuer)
- SEC Form 4 filed by Gudin Jeffrey4 - Virpax Pharmaceuticals, Inc. (0001708331) (Issuer)
- SEC Form 4 filed by Chipman Christopher Michael4 - Virpax Pharmaceuticals, Inc. (0001708331) (Issuer)
- SEC Form 4 filed by Sendrow Jerrold4 - Virpax Pharmaceuticals, Inc. (0001708331) (Issuer)
- SEC Form 4 filed by Floyd Eric4 - Virpax Pharmaceuticals, Inc. (0001708331) (Issuer)
- SEC Form 4 filed by Jambulingam Thani4 - Virpax Pharmaceuticals, Inc. (0001708331) (Issuer)
- SEC Form 4 filed by Dubin Michael F4 - Virpax Pharmaceuticals, Inc. (0001708331) (Issuer)
- SEC Form 4 filed by Singh Vanila4 - Virpax Pharmaceuticals, Inc. (0001708331) (Issuer)
- SEC Form 4: Sendrow Jerrold bought $5,805 worth of shares (4,500 units at $1.29), increasing direct ownership by 100% to 9,006 units4 - Virpax Pharmaceuticals, Inc. (0001708331) (Issuer)
- SEC Form 4: Mack Anthony P. bought $101,505 worth of shares (75,750 units at $1.34), increasing direct ownership by 43% to 252,562 units4 - Virpax Pharmaceuticals, Inc. (0001708331) (Issuer)
- SEC Form 4: Floyd Eric bought $6,107 worth of shares (4,479 units at $1.36), increasing direct ownership by 127% to 8,018 units4 - Virpax Pharmaceuticals, Inc. (0001708331) (Issuer)
- SEC Form 4 filed by Bruce Gerald W4 - Virpax Pharmaceuticals, Inc. (0001708331) (Issuer)
- SEC Form 4 filed by Mack Anthony P.4 - Virpax Pharmaceuticals, Inc. (0001708331) (Issuer)
- SEC Form 4 filed by Gudin Jeffrey4 - Virpax Pharmaceuticals, Inc. (0001708331) (Issuer)
- SEC Form 4 filed by Chipman Christopher Michael4 - Virpax Pharmaceuticals, Inc. (0001708331) (Issuer)
- SEC Form 4 filed by Sendrow Jerrold4 - Virpax Pharmaceuticals, Inc. (0001708331) (Issuer)
- SEC Form 4 filed by Jambulingam Thani4 - Virpax Pharmaceuticals, Inc. (0001708331) (Issuer)
- SEC Form 4 filed by Singh Vanila4 - Virpax Pharmaceuticals, Inc. (0001708331) (Issuer)
- SEC Form 4 filed by Dubin Michael F4 - Virpax Pharmaceuticals, Inc. (0001708331) (Issuer)
- SEC Form 4 filed by Floyd Eric4 - Virpax Pharmaceuticals, Inc. (0001708331) (Issuer)
- SEC Form 4 filed by Jacob Gary S4 - Virpax Pharmaceuticals, Inc. (0001708331) (Issuer)
- SEC Form 4: Mack Anthony P. bought $100,249 worth of shares (25,125 units at $3.99), increasing direct ownership by 17% to 176,812 units4 - Virpax Pharmaceuticals, Inc. (0001708331) (Issuer)
- SEC Form 4 filed by Dubin Michael F4 - Virpax Pharmaceuticals, Inc. (0001708331) (Issuer)
- SEC Form 4 filed by Jeffrey Gudin4 - Virpax Pharmaceuticals, Inc. (0001708331) (Issuer)
- SEC Form 4 filed by Vanila Singh4 - Virpax Pharmaceuticals, Inc. (0001708331) (Issuer)
- SEC Form 4 filed by Thani Jambulingam4 - Virpax Pharmaceuticals, Inc. (0001708331) (Issuer)
- SEC Form 4 filed by Jerrold Sendrow4 - Virpax Pharmaceuticals, Inc. (0001708331) (Issuer)
- SEC Form 4 filed by W Gerald Bruce4 - Virpax Pharmaceuticals, Inc. (0001708331) (Issuer)
- SEC Form 4 filed by Eric Floyd4 - Virpax Pharmaceuticals, Inc. (0001708331) (Issuer)
- SEC Form 4 filed by Michael Christopher Chipman4 - Virpax Pharmaceuticals, Inc. (0001708331) (Issuer)
- SEC Form 4 filed by P. Anthony Mack4 - Virpax Pharmaceuticals, Inc. (0001708331) (Issuer)
- SEC Form 4 filed by S Gary Jacob4 - Virpax Pharmaceuticals, Inc. (0001708331) (Issuer)